Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 125 (Search time: 0.011 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Effect of adherence to protocolized targeted intensifications of disease-modifying antirheumatic drugs on treatment outcomes in rheumatoid arthritis: results from an Australian early arthritis cohortWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2017Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathwaysWalsh, A.; Wechalekar, M.; Guo, Y.; Yin, X.; Weedon, H.; Proudman, S.; Smith, M.; Nagpal, S.
2017A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adultsMorrisroe, K.; Stevens, W.; Proudman, S.; Nikpour, M.
2010Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physiciansMangat, P.; Conron, M.; Gabbay, E.; Proudman, S.
2011Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohortNikpour, M.; Hissaria, P.; Byron, J.; Sahhar, J.; Micallef, M.; Paspaliaris, W.; Roddy, J.; Nash, P.; Sturgess, A.; Proudman, S.; Stevens, W.
2018Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestationsThakkar, V.; Patterson, K.; Stevens, W.; Wilson, M.; Roddy, J.; Sahhar, J.; Proudman, S.; Hissaria, P.; Nikpour, M.
2017Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritisWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; Mcwilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2015Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three yearsWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2015Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseMoore, O.; Proudman, S.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Morrisroe, K.; Thakkar, V.; Sahhar, J.; Roddy, J.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.
2017CD40L-dependent pathway is active at various stages of rheumatoid arthritis disease progressionGuo, Y.; Walsh, A.; Fearon, U.; Smith, M.; Wechalekar, M.; Yin, X.; Cole, S.; Orr, C.; McGarry, T.; Canavan, M.; Kelly, S.; Lin, T.; Liu, X.; Proudman, S.; Veale, D.; Pitzalis, C.; Nagpal, S.